Cargando…

The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome

PURPOSE: Diagnosing corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) is often difficult due to the wide variety of symptoms and overlaps in the similar clinical courses and neurological findings. The purpose of this study was to evaluate the utility of white matter (WM) atrop...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakurai, Keita, Imabayashi, Etsuko, Tokumaru, Aya M., Hasebe, Shin, Murayama, Shigeo, Morimoto, Satoru, Kanemaru, Kazutomi, Takao, Masaki, Shibamoto, Yuta, Matsukawa, Noriyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459051/
https://www.ncbi.nlm.nih.gov/pubmed/26082887
http://dx.doi.org/10.1016/j.nicl.2014.02.009
_version_ 1782375159805509632
author Sakurai, Keita
Imabayashi, Etsuko
Tokumaru, Aya M.
Hasebe, Shin
Murayama, Shigeo
Morimoto, Satoru
Kanemaru, Kazutomi
Takao, Masaki
Shibamoto, Yuta
Matsukawa, Noriyuki
author_facet Sakurai, Keita
Imabayashi, Etsuko
Tokumaru, Aya M.
Hasebe, Shin
Murayama, Shigeo
Morimoto, Satoru
Kanemaru, Kazutomi
Takao, Masaki
Shibamoto, Yuta
Matsukawa, Noriyuki
author_sort Sakurai, Keita
collection PubMed
description PURPOSE: Diagnosing corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) is often difficult due to the wide variety of symptoms and overlaps in the similar clinical courses and neurological findings. The purpose of this study was to evaluate the utility of white matter (WM) atrophy for the diagnosis of patients with clinically diagnosed CBD (corticobasal syndrome, CBS) and PSP (Richardson’s syndrome, RS). METHODS: We randomly divided the 3D T1-weighted MR images of 18 CBS patients, 33 RS patients, and 32 age-matched controls into two groups. We obtained segmented WM images in the first group using Voxel-based specific regional analysis system for Alzheimer’s disease (VSRAD) based on statistical parametric mapping (SPM) 8 plus diffeomorphic anatomical registration through exponentiated Lie algebra. A target volume of interest (VOI) for disease-specific atrophy was subsequently determined in this group using SPM8 group analyses of WM atrophy between patients groups and controls. We then evaluated the utility of these VOIs for diagnosing CBS and RS patients in the second group. Z score values in these VOIs were used as the determinant in receiver operating characteristic (ROC) analyses. RESULTS: Specific target VOIs were determined in the bilateral frontal subcortical WM for CBS and in the midbrain tegmentum for RS. In ROC analyses, the target VOIs of CBS and RS compared to those of controls exhibited an area under curve (AUC) of 0.99 and 0.84, respectively, which indicated an adequate diagnostic power. The VOI of CBS revealed a higher AUC than that of RS for differentiating between CBS and RS (AUC, 0.75 vs 0.53). CONCLUSIONS: Bilateral frontal WM volume reduction demonstrated a higher power for differentiating CBS from RS. This VOI analysis is useful for clinically diagnosing CBS and RS.
format Online
Article
Text
id pubmed-4459051
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-44590512015-06-16 The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome Sakurai, Keita Imabayashi, Etsuko Tokumaru, Aya M. Hasebe, Shin Murayama, Shigeo Morimoto, Satoru Kanemaru, Kazutomi Takao, Masaki Shibamoto, Yuta Matsukawa, Noriyuki Neuroimage Clin Regular Article PURPOSE: Diagnosing corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) is often difficult due to the wide variety of symptoms and overlaps in the similar clinical courses and neurological findings. The purpose of this study was to evaluate the utility of white matter (WM) atrophy for the diagnosis of patients with clinically diagnosed CBD (corticobasal syndrome, CBS) and PSP (Richardson’s syndrome, RS). METHODS: We randomly divided the 3D T1-weighted MR images of 18 CBS patients, 33 RS patients, and 32 age-matched controls into two groups. We obtained segmented WM images in the first group using Voxel-based specific regional analysis system for Alzheimer’s disease (VSRAD) based on statistical parametric mapping (SPM) 8 plus diffeomorphic anatomical registration through exponentiated Lie algebra. A target volume of interest (VOI) for disease-specific atrophy was subsequently determined in this group using SPM8 group analyses of WM atrophy between patients groups and controls. We then evaluated the utility of these VOIs for diagnosing CBS and RS patients in the second group. Z score values in these VOIs were used as the determinant in receiver operating characteristic (ROC) analyses. RESULTS: Specific target VOIs were determined in the bilateral frontal subcortical WM for CBS and in the midbrain tegmentum for RS. In ROC analyses, the target VOIs of CBS and RS compared to those of controls exhibited an area under curve (AUC) of 0.99 and 0.84, respectively, which indicated an adequate diagnostic power. The VOI of CBS revealed a higher AUC than that of RS for differentiating between CBS and RS (AUC, 0.75 vs 0.53). CONCLUSIONS: Bilateral frontal WM volume reduction demonstrated a higher power for differentiating CBS from RS. This VOI analysis is useful for clinically diagnosing CBS and RS. Elsevier 2014-02-27 /pmc/articles/PMC4459051/ /pubmed/26082887 http://dx.doi.org/10.1016/j.nicl.2014.02.009 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
spellingShingle Regular Article
Sakurai, Keita
Imabayashi, Etsuko
Tokumaru, Aya M.
Hasebe, Shin
Murayama, Shigeo
Morimoto, Satoru
Kanemaru, Kazutomi
Takao, Masaki
Shibamoto, Yuta
Matsukawa, Noriyuki
The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome
title The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome
title_full The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome
title_fullStr The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome
title_full_unstemmed The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome
title_short The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson’s syndrome
title_sort feasibility of white matter volume reduction analysis using spm8 plus dartel for the diagnosis of patients with clinically diagnosed corticobasal syndrome and richardson’s syndrome
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459051/
https://www.ncbi.nlm.nih.gov/pubmed/26082887
http://dx.doi.org/10.1016/j.nicl.2014.02.009
work_keys_str_mv AT sakuraikeita thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT imabayashietsuko thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT tokumaruayam thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT hasebeshin thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT murayamashigeo thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT morimotosatoru thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT kanemarukazutomi thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT takaomasaki thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT shibamotoyuta thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT matsukawanoriyuki thefeasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT sakuraikeita feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT imabayashietsuko feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT tokumaruayam feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT hasebeshin feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT murayamashigeo feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT morimotosatoru feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT kanemarukazutomi feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT takaomasaki feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT shibamotoyuta feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome
AT matsukawanoriyuki feasibilityofwhitemattervolumereductionanalysisusingspm8plusdartelforthediagnosisofpatientswithclinicallydiagnosedcorticobasalsyndromeandrichardsonssyndrome